Raleigh Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66	Closed	-$6.68K	–	891
2023 Q1	$6.68K	Buy	66 +29	+78%	+$2.94K	﹤0.01%	576
2022 Q4	$4.42K	Buy	37 +10	+37%	+$1.19K	﹤0.01%	566
2022 Q3	$3K	Buy	+27	New	+$3K	﹤0.01%	600